ArticleJournal of pharmacy & bioallied sciences2025
Enhancing Male Fertility Through Nutrition: The Role of L-Carnitine in Asthenozoospermic Patients.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infertility, which affects millions worldwide, often involves male factors such as asthenozoospermia, a condition marked by reduced sperm motility. While lifestyle and environmental factors are major contributors, nutritional interventions offer an effective, non-invasive approach to treatment. This case report examines the effects of L-carnitine supplementation on male infertility in a 37-year-old patient with a six-year history of primary infertility. The patient followed a three-month protocol that included 3000 mg of L-carnitine daily, dietary changes rich in antioxidants, and lifestyle modifications. Initial semen analysis revealed significant deficiencies, including progressive motility of 15% and a sperm count of 25 million/mL. After the intervention, notable improvements were observed: progressive motility increased to 50%, sperm count rose to 49 million/mL, and normal morphology improved from 3% to 7%. These results highlight the role of L-carnitine in supporting sperm mitochondrial function, reducing oxidative stress, and improving key fertility parameters. The findings are consistent with existing research demonstrating the potential of L-carnitine as a treatment for male infertility. This report underscores the value of individualized nutritional and supplementation strategies in enhancing reproductive health and suggests L-carnitine as a safe and effective option for treating asthenozoospermia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.